Integrated Hedgehog signaling is induced following castration in human and murine prostate cancers

Prostate

Volumn 73, Issue 2, 2013, Pages 153-161

  Efstathiou, Eleni ^a,b   Karlou, Maria ^c   Wen, Sijin ^c   Hoang, Anh ^c   Pettaway, Curtis A ^c   Pisters, Louis L ^c   Maity, Sankar ^b   Troncoso, Patricia ^c   Logothetis, Christopher J ^b,c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b David H Koch Center for Applied Research of Genitourinary Cancers   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

androgen ablation; Hedgehog signaling; preoperative treatment; prostate cancer; resistance to treatment

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; ANDROGEN RECEPTOR; CYTOCHROME P450 17; DOXORUBICIN; ESTRAMUSTINE; GONADORELIN AGONIST; HYDROCORTISONE; KETOCONAZOLE; KI 67 ANTIGEN; PROSTATE SPECIFIC ANTIGEN; PROTEIN BCL 2; SONIC HEDGEHOG PROTEIN; VASCULOTROPIN; VINBLASTINE;

ADVANCED CANCER; ANDROGEN DEPRIVATION THERAPY; CANCER CHEMOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TUMOR XENOGRAFT;

ADENOCARCINOMA; ADULT; AGED; ANDROGEN ANTAGONISTS; ANIMALS; CELL LINE, TUMOR; HEDGEHOG PROTEINS; HUMANS; MALE; MICE; MIDDLE AGED; ORCHIECTOMY; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84871618345     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22550     Document Type: Conference Paper

References (20)

1. Attard G, Reid AH, Olmos D, de Bono JS,. Antitumor activity with CYP17 blockade indicates that castration-resistant prostate cancer frequently remains hormone driven. Cancer Res 2009; 69 (12): 4937-4940.
2. Stanbrough M, Bubley GJ, Ross K, Golub TR, Rubin MA, Penning TM, Febbo PG, Balk SP,. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res 2006; 66 (5): 2815-2825.
3. Montgomery RB, Mostaghel EA, Vessella R, Hess DL, Kalhorn TF, Higano CS, True LD, Nelson PS,. Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth. Cancer Res 2008; 68 (11): 4447-4454.
4. Karhadkar SS, Bova GS, Abdallah N, Dhara S, Gardner D, Maitra A, Isaacs JT, Berman DM, Beachy PA,. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 2004; 431 (7009): 707-712.
5. Sanchez P, Hernández AM, Stecca B, Kahler AJ, DeGueme AM, Barrett A, Beyna M, Datta MW, Datta S, Ruiz i Altaba A,. Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. Proc Natl Acad Sci USA 2004; 101 (34): 12561-12566.
6. Navone NM, Olive M, Ozen M, Davis R, Troncoso P, Tu SM, Johnston D, Pollack A, von Eschenbach AC, Logothetis CJ,. Establishment of two human prostate cancer cell lines derived from a single bone metastasis. Clin Cancer Res 1997; 3 (12 Pt 1): 2493-2500.
7. Riobo NA, Manning DR,. Pathways of signal transduction employed by vertebrate Hedgehogs. Biochem J 2007; 403 (3): 369-379.
8. Thiyagarajan S, Bhatia N, Reagan-Shaw S, Cozma D, Thomas Tikhonenko A, Ahmad N, Spiegelman VS,. Role of GLI2 transcription factor in growth and tumorigenicity of prostate cells. Cancer Res 2007; 67 (22): 10642-10646.
9. Efstathiou E, Troncoso P, Wen S, Do KA, Pettaway CA, Pisters LL, McDonnell TJ, Logothetis CJ,. Initial modulation of the tumor microenvironment accounts for thalidomide activity in prostate cancer. Clin Cancer Res 2007; 13 (4): 1224-1231.
10. Logothetis CJ, Navone NM, Lin SH,. Understanding the biology of bone metastases: Key to the effective treatment of prostate cancer. Clin Cancer Res 2008; 14 (6): 1599-1602.
11. Loberg RD, Logothetis CJ, Keller ET, Pienta KJ,. Pathogenesis and treatment of prostate cancer bone metastases: Targeting the lethal phenotype. J Clin Oncol 2005; 23 (32): 8232-8241.
12. Berman DM, Desai N, Wang X, Karhadkar SS, Reynon M, Abate-Shen C, Beachy PA, Shen MM,. Roles for Hedgehog signaling in androgen production and prostate ductal morphogenesis. Dev Biol 2004; 267 (2): 387-398.
13. Casali A, Struhl G,. Reading the Hedgehog morphogen gradient by measuring the ratio of bound to unbound Patched protein. Nature 2004; 431 (7004): 76-80.
14. Chen M, Tanner M, Levine AC, Levina E, Ohouo P, Buttyan R,. Androgenic regulation of hedgehog signaling pathway components in prostate cancer cells. Cell Cycle 2009; 8 (1): 149-157.
15. Yauch RL, Gould SE, Scales SJ, Tang T, Tian H, Ahn CP, Marshall D, Fu L, Januario T, Kallop D, Nannini-Pepe M, Kotkow K, Marsters JC, Rubin LL, de Sauvage FJ,. A paracrine requirement for hedgehog signalling in cancer. Nature 2008; 455 (7211): 406-410.
16. Ruiz i Altaba A,. Therapeutic inhibition of Hedgehog-GLI signaling in cancer: Epithelial, stromal, or stem cell targets ? Cancer Cell 2008; 14 (4): 281-283.
17. Karlou M, Lu JF, Wu G, Maity S, Tzelepi V, Navone NM, Hoang A, Logothetis CJ, Efstathiou E,. Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC-0449 in the bone forming prostate cancer xenograft MDA PCa 118b. Prostate 2012; DOI: 10.1002/pros.22517.
18. Narita S, So A, Ettinger S, Hayashi N, Muramaki M, Fazli L, Kim Y, Gleave ME,. GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancer. Clin Cancer Res 2008; 14 (18): 5769-5777.
19. Linja MJ, Savinainen KJ, Saramäki OR, Tammela TL, Vessela RL, Visakorpi T,. Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res 2001; 61 (9): 3550-3555.
20. Efstathiou E, Logothetis CJ,. A new therapy paradigm for prostate cancer founded on clinical observations. Clin Cancer Res 2010; 16 (4): 1100-1117.